Bionano Genomics, Inc.
BNGO • NASDAQ
Bionano Genomics, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Mark Oldakowski, with a market cap of $12.9M.
Market Cap$12.9M
Employees344.0
CEOMark Oldakowski
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Bionano Genomics, Inc. FAQ
Common questions about Bionano Genomics, Inc.
Bionano Genomics, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $6.6M.
Bionano Genomics, Inc. has approximately 344 employees.